Form 4 for OM Outset Medical, Inc.
Accepted 2022-05-03 00:00:00 ET · period of report 2022-05-02 · accession 0001484612-22-000037 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-05-03 | 2022-05-02 | OM | Ahmed Nabeel | CFO | M - OptEx | $9.48 | +200 | 44.7K | +0.4% | +$1,896 |
| D | 2022-05-03 | 2022-05-02 | OM | Ahmed Nabeel | CFO | S - Sale+OE | $35.00 | -200 | 44.5K | -0.4% | -$7,000 |
| D | 2022-05-03 | 2022-05-02 | OM | Ahmed Nabeel | CFO | M - OptEx | $0.00 | -200 | 10.1K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-02 | M | A | 200 | $9.48 | 44,689 | D | — | — | |
| 2 | Common | Common Stock | 2022-05-02 | S | D | 200 | $35.00 | 44,489 | D | — | — | |
| 3 | Derivative | Performance Options (right to buy) | 2022-05-02 | M | D | 200 | $0.00 | 10,132 | D | $9.48 · — to 2030-05-26 | 200 Common Stock | (F2) In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested. |